발광 특성을 갖는 나프토아크리딘 화합물
    23.
    发明公开
    발광 특성을 갖는 나프토아크리딘 화합물 有权
    具有发光性能的萘普生化合物

    公开(公告)号:KR1020120103322A

    公开(公告)日:2012-09-19

    申请号:KR1020110021512

    申请日:2011-03-10

    CPC classification number: C07D219/00 H01L51/0067 H01L51/0072 H05B33/20

    Abstract: PURPOSE: A naphtoacridine compound is provided to be used as fluorescent or luminous dye, or to be used as fluorescent or luminous material for organic electroluminescence devices by having a property excited by a wavelength of UV rays or visible rays. CONSTITUTION: A naphtoacridine compound is in chemical formula 1. The naphtoacridine compound in chemical formula 1 is manufactured by witting reaction of 9H-naphtho[3,2,1-kl]acridin-9-one and triphenylphosphonium bromide in chemical formula 3. In the chemical formulas, R^1 and R^2 is the same or different each other, selected from a phenyl group, a biphenyl group, a naphthalene group, a pyridine group. The witting reaction is conducted with a base of C1-6 alkoxy alkali metal salt under the condition of inert condition.

    Abstract translation: 目的:提供萘吖啶化合物用作荧光或发光染料,或者通过具有由紫外线或可见光线的波长激发的特性用作有机电致发光器件的荧光或发光材料。 化学式1中的萘吖啶化合物通过化学式3中9H-萘并[3,2,1-kl]吖啶-9-酮和三苯基溴化鏻的反应而制备。在 化学式R 1和R 2彼此相同或不同,选自苯基,联苯基,萘基,吡啶基。 在惰性条件下,用C1-6烷氧基碱金属盐的碱进行催化反应。

    신규 피롤로[3,2-b]피리딘 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 흑색종 예방 또는 치료용 약학적 조성물
    24.
    发明公开
    신규 피롤로[3,2-b]피리딘 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 흑색종 예방 또는 치료용 약학적 조성물 失效
    新型吡咯并[3,2-B]吡啶衍生物或其药学上可接受的盐,其制备方法和药物组合物,用于预防或治疗含有作为活性成分的梅毒

    公开(公告)号:KR1020100047998A

    公开(公告)日:2010-05-11

    申请号:KR1020080106962

    申请日:2008-10-30

    Abstract: PURPOSE: A novel pyrollo[3,2-b]pyridine derivative and a pharmaceutical composition for preventing or treating melanoma containing the same are provided to ensure high anti-proliferative activity to melanoma cells. CONSTITUTION: A pyrollo(3,2-b)pyridine derivative is denoted by chemical formula 1. A method for preparing the pirrolo(3,2,-b)pyridine derivative comprises: a step of coupling 1-iodine-4-nitrobenze to a compound of chemical formula 2 to obtain a compound of chemical formula 3; a step of reducing the compound of chemical formula 3 to obtain a compound of chemical formula 4; and a step of coupling the compound of chemical formula 4 with a phenylcarboxylic acid or amine derivative which trifluoromethyl, halogen, morpholine, piperazine. A pharmaceutical composition for preventing or treating melanoma contains the pyrollo(3,2-b)pyridine derivative or pharmaceutically acceptable salt as an active ingredient.

    Abstract translation: 目的:提供一种新型的吡咯并[3,2-b]吡啶衍生物和用于预防或治疗含有此类黑色素瘤的药物组合物,以确保对黑素瘤细胞的高抗增殖活性。 构成:吡咯(3,2-b)吡啶衍生物由化学式1表示。制备吡罗咯(3,2,-b)吡啶衍生物的方法包括:将1-碘-4-硝基苯偶联到 化学式2的化合物,得到化学式3的化合物; 还原化学式3的化合物以获得化学式4的化合物的步骤; 以及将化学式4的化合物与三氟甲基,卤素,吗啉,哌嗪的苯基羧酸或胺衍生物偶合的步骤。 用于预防或治疗黑素瘤的药物组合物含有吡罗洛(3,2-b)吡啶衍生物或其药学上可接受的盐作为活性成分。

    가라민 유도체의 제조방법
    25.
    发明授权
    가라민 유도체의 제조방법 有权
    가라민유도체의제조방법

    公开(公告)号:KR100450607B1

    公开(公告)日:2004-09-30

    申请号:KR1020020040324

    申请日:2002-07-11

    Abstract: PURPOSE: A process for preparing Gallamine derivative is provided, thereby cheaply preparing the Gallamine derivative which is useful in synthesis of aminoglycoside antibiotics including isepamycin. CONSTITUTION: A process for preparing Gallamine derivative of the formula(4) comprises the steps of: introducing acetyl(-Ac) or benzyloxycarbonyl(-Cbz) into the amine group of 3,2',6'-NH2 of sisomicin or gentamicin to prepare a compound of the formula(1); reacting the amine group of 1-NH2 of the compound of the formula(1) with anhydride of acid represented by YOH or acid derivative thereof to prepare a compound of the formula(2); introducing acetyl(-Ac) or benzyloxycarbonyl(-Cbz) into the amine group of 3'-NH2 of the compound of the formula(2) to prepare a compound of the formula(3); and reacting the compound of the formula(3) under acid condition to remove purpurosamine or sisosamine ring to prepare the Gallamine derivative of the formula(4), wherein R1 and R2 are independently hydrogen or methyl; X is acetyl or benzyloxycarbonyl; Y is C1 to C10 alkylcarbonyl, or amino or hydroxy substituted C1 to C10 alkylcarbonyl.

    Abstract translation: 目的:提供了一种制备Gallamine衍生物的方法,由此便宜地制备了用于合成氨基糖苷类抗生素(包括异阿霉素)的Gallamine衍生物。 构成:制备式(4)的Gallamine衍生物的方法包括以下步骤:将乙酰基(-Ac)或苄氧基羰基(-Cbz)引入西索米星或庆大霉素的3,2',6'-NH 2的胺基中, 制备式(1)的化合物; 使式(1)化合物的1-NH 2的胺基与由YOH或其酸衍生物表示的酸的酸酐反应以制备式(2)的化合物; 在式(2)化合物的3'-NH 2的胺基中引入乙酰基(-Ac)或苄氧基羰基(-Cbz)以制备式(3)的化合物; (3)的化合物在酸性条件下反应以除去紫苏糖胺或sisosamine环以制备式(4)的Gallamine衍生物,其中R 1和R 2独立地为氢或甲基; X是乙酰基或苄氧基羰基; Y是C1至C10烷基羰基,或氨基或羟基取代的C1至C10烷基羰基。

    2-아세틸니코티닉산의 제조방법
    26.
    发明公开
    2-아세틸니코티닉산의 제조방법 失效
    2-乙酰胆碱酸的制备方法

    公开(公告)号:KR1020020059999A

    公开(公告)日:2002-07-16

    申请号:KR1020010001195

    申请日:2001-01-09

    Abstract: PURPOSE: A method for preparing 2-acetylnicotinic acid is provided to improve the deoxygenating process, thereby reducing the environmental pollution and the manufacturing cost and enhancing production yield and purity. CONSTITUTION: The method comprises the steps of acetylating nicotinic acid N-oxide, deoxygenating the acetylated compound; and treating the deoxygenated compound with an alkali or acid aqueous solution to obtain 2-acetylnicotinic acid, wherein the deoxygenation is carried out by using an alcohol solvent and a Pd/C catalyst under the hydrogen gas atmosphere. Preferably the deoxygenation is carried out at 0.5-3 % Pd/C catalyst in alcohols and at a hydrogen gas pressure of 1-10 atm.

    Abstract translation: 目的:提供2-乙酰烟酸的制备方法,以改善脱氧过程,减少环境污染和制造成本,提高产量和纯度。 方法:该方法包括乙酰化烟酸N-氧化物,脱乙酰化化合物的步骤; 用碱或酸水溶液处理脱氧化合物,得到2-乙酰烟酸,其中,在氢气气氛下使用醇溶剂和Pd / C催化剂进行脱氧。 优选地,脱氧在0.5-3%Pd / C催化剂的醇中和氢气压力为1-10atm下进行。

    4급 비대칭탄소를 함유하는 라세미체 알콜 화합물의 분할방법과 시스탄 유사체의 합성
    27.
    发明授权
    4급 비대칭탄소를 함유하는 라세미체 알콜 화합물의 분할방법과 시스탄 유사체의 합성 失效
    4含有季铵手性碳的外消旋醇化合物的解决方法和合成季铵衍生物的方法

    公开(公告)号:KR100341255B1

    公开(公告)日:2002-06-21

    申请号:KR1019990038840

    申请日:1999-09-11

    Abstract: 본발명은살균제로서우수한아졸화합물인시스탄의비대칭합성에있어화학식 1과같은중간체로적절히고안된 4급비대칭탄소를함유한알콜화합물의라세미체를유기용매중에서아실주게의존재하에 0 ∼ 60 ℃의온도에서리파제로트랜스에스테르화반응또는그 알콜의에스테르에대한가수분해반응을통하여광학적으로순수한각각의 R- 및 S-이성질체로분할하는방법과분할된각 이성질체로부터시스탄과그 유도체의합성방법에관한것이다. 식중, X는수소또는할로겐이며, n은탄소의수를나타내는것으로본 발명에서는 X는수소또는벤젠고리의탄소-4 위치에염소로치환된화합물과히드록시기가있는탄소의수를 1, 2, 3, 4로변환하여합성하였다. 합성한라세미체알콜들을리파제를사용하여 n=1인화합물은완전히분할하여목적화합물인아졸화합물을합성하였다. 사용한리파제들의 4급비대칭탄소에대한인지능력을측정하기위하여 n를증가시켜합성하여트랜스에스테르화반응을수행하였다. 분할을향상시키기위하여반응중 발생하는알데히드를제거할수 있는시약으로아민류를선정하여분할을향상시켰다.

    화합물 및 이를 이용한 유기전기소자, 그 단말
    30.
    发明公开
    화합물 및 이를 이용한 유기전기소자, 그 단말 有权
    化学和有机电子元件使用它,终端

    公开(公告)号:KR1020120054154A

    公开(公告)日:2012-05-30

    申请号:KR1020100115398

    申请日:2010-11-19

    Abstract: PURPOSE: A compound containing quinoxalicarbazole and an organic electric device using the same are provided to be used as a host material of a phosphor dopant of various colors. CONSTITUTION: An organic electric device contains one or more organic layers containing a compound containing quinoxalinocabazole of chemical formula 1. The organic electric device comprises a first electrode, one or more organic layers and second electrode. The organic layer includes a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, an electron injection layer, and a light emitting layer. A terminal comprises a display device and a control unit.

    Abstract translation: 目的:提供含有喹喔啉咔唑的化合物和使用其的有机电子装置,用作各种颜色的磷光体掺杂剂的主体材料。 构成:有机电气装置含有一种或多种含有化学式1的喹喔啉酮化合物的有机层。有机电子装置包括第一电极,一个或多个有机层和第二电极。 有机层包括空穴注入层,空穴传输层,发光层,电子传输层,电子注入层和发光层。 终端包括显示设备和控制单元。

Patent Agency Ranking